Kancera Ab Stock Shares Owned By Insiders
| KAN Stock | SEK 1.42 0.04 2.74% |
Kancera AB's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Kancera Stock price.
Kancera |
Kancera AB Company Shares Owned By Insiders Analysis
Kancera AB's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Kancera AB Shares Owned By Insiders | 13.72 % |
Most of Kancera AB's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kancera AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 13.72% of Kancera AB are shares owned by insiders. This is 9.62% lower than that of the Healthcare sector and 3.24% lower than that of the Biotechnology industry. The shares owned by insiders for all Sweden stocks is 35.98% lower than that of the firm.
Kancera Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kancera AB's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kancera AB could also be used in its relative valuation, which is a method of valuing Kancera AB by comparing valuation metrics of similar companies.Kancera AB is currently under evaluation in shares owned by insiders category among its peers.
Kancera Fundamentals
| Return On Equity | -0.47 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (72.39) % | |||
| Current Valuation | 14.76 M | |||
| Shares Outstanding | 79.53 M | |||
| Shares Owned By Insiders | 13.72 % | |||
| Shares Owned By Institutions | 2.86 % | |||
| Price To Earning | (11.64) X | |||
| Price To Book | 1.44 X | |||
| Price To Sales | 168.19 X | |||
| Revenue | 1.7 M | |||
| Gross Profit | 1.7 M | |||
| EBITDA | (45.35 M) | |||
| Net Income | (45.69 M) | |||
| Cash And Equivalents | 106.52 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 442 K | |||
| Debt To Equity | 33.30 % | |||
| Current Ratio | 2.11 X | |||
| Book Value Per Share | 1.50 X | |||
| Cash Flow From Operations | (44.12 M) | |||
| Earnings Per Share | (0.87) X | |||
| Target Price | 1.6 | |||
| Beta | 1.28 | |||
| Market Capitalization | 262.69 M | |||
| Total Asset | 133.64 M | |||
| Working Capital | 11 M | |||
| Current Asset | 16 M | |||
| Current Liabilities | 5 M | |||
| Net Asset | 133.64 M |
About Kancera AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kancera AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kancera AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kancera AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kancera Stock Analysis
When running Kancera AB's price analysis, check to measure Kancera AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kancera AB is operating at the current time. Most of Kancera AB's value examination focuses on studying past and present price action to predict the probability of Kancera AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kancera AB's price. Additionally, you may evaluate how the addition of Kancera AB to your portfolios can decrease your overall portfolio volatility.